SYNE1 and hepatocellular carcinoma: Two independent shRNA clones, #1 and #2, were obtained and their efficiencies to knockdown SYNE1, either in HCC (Mahlavu) or in TCC (u1) cell lines, were evaluated accordingly (Figure 3A,B).